Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.60
Bid: 2.50
Ask: 2.70
Change: -0.05 (-1.89%)
Spread: 0.20 (8.00%)
Open: 2.65
High: 2.65
Low: 2.60
Prev. Close: 2.65
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: ValiRx receives shareholder request for board change

Fri, 09th Feb 2024 20:24

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Says it has received a requisition notice from a shareholder group proposing certain changes to the board. Seeks legal advice as to the validity of the requisition notice and a further announcement will be made in due course.

----------

The Property Franchise Group PLC - Bournemouth, England-based lettings and estate agency franchising firm - Reports close to 100% shareholder backing for the all-share merger with The Belvoir Group PLC at the General Meeting.

----------

Kin and Carta PLC - London-based business software consultancy - Ahead of the Court Meeting and General Meeting, reiterates unanimous recommendation that scheme shareholders vote in favour of the scheme at the Court Meeting and the special resolution proposed at the General Meeting. This is to facilitate the bid for Kin and Carta by Valtech. Points out that Apax Partners, which had also made a bid for the company, said Friday it would not increasing the terms of its 120 pence per share offer. Valtech's bid is worth 130p per Kin and Carta share. Explains discussions with other parties had not led to a bid for the company, and no talks are currently ongoing.

----------

Catenae Innovation PLC - London-based digital media and technology provider using blockchain technology to support clients with operations and staff management - Says at Annual General Meeting all resolutions were passed including name change to Catenai PLC and the share capital reorganisation. Once the change of name takes effect, the group's ticker for AIM will be CTAI.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
5 Feb 2015 08:18

ValiRx Buys Finnish Gene Expression And Biomarker Technology

Read more
15 Jan 2015 10:36

ValiRx Expects First VAL201 Results In 1st Quarter; VAL401 Progresses

Read more
13 Nov 2014 09:47

ValiRx Enters Collaboration Agreement For GeneICE Development

Read more
3 Nov 2014 11:09

ValiRx VAL201 PhaseI/II Trial Progressing In Line With Plan

Read more
14 Oct 2014 09:22

ValiRx VAL201 Phase I/II Trial Ready To Begin Recruitment

Read more
8 Oct 2014 15:31

ValiRx Completes YA Global Master Equity Swap Deal Early

Read more
2 Sep 2014 09:27

Valirx's lung cancer treatment receives positive results

Valirx, the developer and producer of technology used in oncology therapeutics, has received positive results from the studies on one of its lung cancer treatments. The studies on treatment VAL401 were carried out by Valiseek, Valirx's joint venture company with Tangent Reprofiling, and demonstrate

Read more
2 Sep 2014 07:26

UK MORNING BRIEFING: Weir Group Leads Firm London Market On Upgrade

Read more
2 Sep 2014 06:40

ValiRx Says Preclinical Trials For VAL401 In Lung Cancer Positive

Read more
19 Aug 2014 10:08

ValiRx Narrows Half-Year Loss On Lower Costs, Progresses Pipeline

Read more
4 Aug 2014 11:12

UK MIDDAY BRIEFING: HSBC Results Below Expectations

Read more
4 Aug 2014 10:49

UK WINNERS & LOSERS: HSBC And Intertek Rise Despite Lower Profit

Read more
4 Aug 2014 07:36

ValiRx Gets Authorisation For VAL201 Trials, Shares Jump

Read more
4 Aug 2014 07:34

UK MORNING BRIEFING: UK Shares Flat Ahead Of HSBC Results

Read more
24 Jun 2014 09:23

DIRECTOR DEALINGS: ValiRx Directors Buy 5.3 Million Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.